8:00 am
Phillip Chang
Phillip Chang, MD, FACS
Chief Medical Officer
University of Kentucky HealthCare

Martha Temple
Martha Temple
Chief Executive Officer
Optum Behavioral Health

8:05 am

There is a national commitment from lawmakers, regulatory agencies, health care organizations, pharmaceutical companies, law enforcement, professional societies, community organizations, private stakeholders, and others to address the opioid crisis impacting the country. In this Keynote Address, gain insight into how Washington is working to address the issue.

  • Learn about proposed legislation and federal recommendations introduced to address the epidemic
  • Hear about efforts being led in Oklahoma to bring down the rate of opioid overdoses
  • Participate in a Q&A with the Congressman to get further insight into initiatives taking place on the Hill

Congressman Mullin is a member of the Health Subcommittee on the House Energy and Commerce Committee. He introduced H.R. 3528, the Every Prescription Conveyed Securely (EPCS) Act, in the House of Representatives on July 28, 2017. The EPCS Act would require electronic prescriptions for all controlled substances under Medicare. The bill compliments state law, which already requires doctors in Oklahoma to check an online database called the Oklahoma Prescription Monitoring Program (PMP) when prescribing controlled substances to new patients.

Congressman Mullin is also the lead sponsor of H.R. 3545, the Overdose Prevention and Patient Safety Act, which would give doctors crucial information about patients medical history prior to treating them and protects patients by updating 42 Code of Federal Regulations (CFR) Part 2, often referred to as “Part 2.”

Markwayne Mullin
Markwayne Mullin
Congressman, Oklahoma 2nd District
Member, Health Subcommittee on the House Energy and Commerce Committee
U.S. House of Representatives

Facilitated By:
Christine Vestal
Christine Vestal
Senior Writer
Pew Charitable Trusts

8:30 am

While many hospitals and health systems are developing initiatives to help stem the opioid crisis, these programs tend to be siloed. In order to attack this problem, health care organizations must develop strategies that address all areas of opioid management; prevention, monitoring, and treatment. Learn how the creation of an opioid stewardship program can be used as the center of a comprehensive system-wide strategy.

  • Examine the components of a detailed needs assessment to determine areas of focus
  • Create a multidisciplinary program through inclusion of stakeholders across the care continuum such as physicians, pharmacists, nurses, etc.
Phillip Chang
Phillip Chang, MD, FACS
Chief Medical Officer
University of Kentucky HealthCare

Douglas Oyler
Douglas Oyler
Chair, Opioid Stewardship
University of Kentucky HealthCare

Peter Hill
Peter Hill, MD
Senior Vice President, Medical Affairs, Johns Hopkins Health System;
Vice President, Medical Affairs, The Johns Hopkins Hospital

9:30 am

Learn how Horizon Blue Cross Blue Shield of New Jersey is working to improve the access and quality of substance abuse treatment through innovative collaborative care and awareness programs with health systems and community partners – including, peer recovery models, intensive case management, and a community town hall series. Also, learn how Horizon BCBSNJ is using advanced analytics to identify combinations of prescribers, patients, and pharmacies at risk for misuse.

Mary Ann Christopher
Mary Ann Christopher, MSN, RN, FAAN
Chief of Clinical Operations and Transformation
Horizon Blue Cross Blue Shield of New Jersey

10:45 am

Clinical leaders are looking at system-wide approaches to work with providers within their hospitals and health systems to reduce opioid-related harms while meeting the needs of patients by creating education, guidelines, and workflow recommendations to affect opioid prescribing practices.

  • Examine the use of CDC guidelines, AMA resources, state guidelines, and other evidence-based clinical recommendations
  • Describe organizational policies, protocols, and programs being deployed at various health systems
  • Discuss ways to improve communication between clinicians and patients about the benefits and risks of prescription opioids, effective alternative therapies available, and treatment agreements
  • Share strategies to address stigmas faced by both providers and patients


Ali Mchourab
Ali Mchourab, MD
Chief, Pain Medicine Service, Northeast Ohio VA Health Care System,
Director, Cleveland VA-ECHO Project


Laura Balsamini
Laura Balsamini, PharmD, BCPS
Director of Pharmacy Services
Summit Medical Group of New Jersey

David Hasleton
David Hasleton, MD
Associate Chief Medical Officer
Intermountain Healthcare

Richard L. Snyder
Richard L. Snyder, MD
Senior Vice President, Chief Medical Officer, Clinical Care Transformation Officer
Independence Blue Cross

11:30 am

The Opioid Crisis affects people all across the nation. However, rural populations are at a much higher risk due to limited resources and distance to major metropolitan health systems. Lack of convenient access to large health care systems results in significant treatment challenges. Health care organizations must use innovative treatment models and technology in order to overcome these obstacles.

  • Develop a “hub and spoke” model of treatment in order to reach out to affected remote patients and communities
  • Use technology such as telemedicine to address treatment issues based on distance
  • Provide education to primary care providers in the community to ensure appropriate prescribing of opioids
Garrett E. Moran
Garrett E. Moran, PhD
Project Director
AHRQ Academy for Integrating Behavioral Health and Primary Care

Faith Kirkham Hawkins
Faith Kirkham Hawkins, PhD
Associate Vice President, Research Development and Strategic Research Initiatives
Indiana University

12:15 pm
1:15 pm

Monitoring data has identified trends in physician prescribing behavior that showcases specific and actionable issues. Health care systems currently have a number of tools and techniques at their disposal to effectively track opioid prescribing, distribution, and patient usage. This session reviews best practices for monitoring physician prescribing practices and patient use, and discuss ways in which hospitals and health systems can improve.

  • Discuss ways health IT and analytics can aid decision making, identify trends, and help manage vast amounts of data to improve care
  • Address the challenge of introducing physician practice change regarding opiates and strategies for achieving “buy-in” from the physician practice
  • Examine the challenges and opportunities around more effective use of PDMPs
  • Discuss ways to address the resources necessary to effectively monitor patients to detect aberrant behavior earlier, intervene earlier, and prevent misuse
  • Share proven patient monitoring techniques to identify potential misuse


Scott LaNeve
Scott LaNeve
Senior Vice President, Health and Patient Care Systems
HealthTrack RX


Brian Konowalchuk
Brian Konowalchuk, MD
Chair, Essentia Opiate Oversight Committee
Essentia Health

Palmer MacKie
Palmer MacKie, MD, MS
Director, Integrative Pain Program, Eskenazi Health, Clinical Assistant Professor, Department of Neurology and Medicine, Indiana University School of Medicine

2:00 pm

High performing initiatives are successful due to both the provider organization and their health plan partners bringing unique attributes to the table. The current opioid epidemic involves multiple stakeholders in the health care arena. In order to effectively address the issues affecting these parties, the role of each stakeholder must be identified and partnerships developed to address the epidemic from a population and individual standpoint.

  • Learn how Geisinger developed partnerships between the payer and provider service lines to provide a comprehensive approach to tackling the opioid epidemic
  • Discuss the value each partner brings to the initiative and how to create greater impact by working together
  • Discover how Geisinger overcame organizational siloes in order to achieve shared goals
Jordan Barbour
Jordan Barbour, MPH
Director, Clinical Operations, Psychiatry, and Addiction Medicine
Geisinger Health

Perry Meadows
Perry Meadows, MD, JD, MBA
Medical Director, Government Programs
Geisinger Health Plan

3:15 pm

Heath care organizations are working hand-in-glove with their community partners to develop grass roots initiatives. Learn about innovative community partnerships and programs that health care organizations have collaborated on together.

  • Discuss ways that health care organizations have been able to leverage the reach and involvement of local organizations to deliver educational and medical resources to individuals
  • Examines ways technology, such as telemedicine, is being used to address access issues based on geographic location
  • Identify resources and supports to address social determinants of health impacting individuals at risk or suffering from opioid dependence or OUD


Perry Meadows
Perry Meadows, MD, JD, MBA
Medical Director, Government Programs
Geisinger Health Plan


Alexander Chan
Alexander Chan
Chief Executive Officer, Clinton Health Matters Initiative
Clinton Foundation

Bryan Cote
Bryan Cote, MA
Founder, Migrant Family Health Network, Managing Director
Berkeley Research Group

Michelle J. Lyn
Michelle J. Lyn, MBA, MHA
Assistant Professor and Chief, Division of Community Health, Department of Community and Family Medicine
Duke University School of Medicine

Martha Temple
Martha Temple
Chief Executive Officer
Optum Behavioral Health

4:00 pm

Available treatment options for Opioid dependence and Opioid Use Disorder such as Medication Assisted Therapy and Cognitive Behavioral Therapy show to be more effective than past treatment choices. However, there are many pitfalls that hinder the ability of health care organizations to implement these treatments on a large scale. This panel discusses ways that health care organizations navigate the continuum of care and apply alternative treatment options.

  • Work with post-acute and rehab facilities to manage transitions of care
  • Examine options and challenges for multimodal OUD treatments
  • Discuss ways to recruit and train clinicians to be able to use MAT to maximize the benefits of this treatment and improve outcomes
  • Create system-wide standards of care for inpatient OUD treatment
  • Discuss successful approaches to implementing a drug take back program


JJ Janoyan
JJ Janoyan, DO, SFHM, CPE
Medical Director, UT Hospitalists
University of Tennessee Medical Center, Knoxville TN

Brian Swift
Brian Swift, PharmD, MBA
Vice President, Chief Pharmacy Officer
Thomas Jefferson University Hospitals

Tammy Tucker
Tammy Tucker, PsyD
Associate Administrator
Memorial Healthcare System

Jordan Hansen
Jordan Hansen, MA, LADC
COR-12 Program Manager
Hazelden Betty Ford Foundation